INVO Fertility Reports Unregistered Equity Sale
Ticker: IVF · Form: 8-K · Filed: Oct 22, 2025 · CIK: 1417926
Sentiment: neutral
Topics: unregistered-securities, equity-sale
TL;DR
INVO Fertility sold unregistered equity, details TBD.
AI Summary
On October 16, 2025, INVO Fertility, Inc. reported an unregistered sale of equity securities. The filing does not disclose the specific number of shares sold or the price per share, but it indicates a transaction occurred on this date.
Why It Matters
This filing indicates a potential dilution of existing shares or a new funding source for INVO Fertility, Inc., which could impact its financial structure and stock value.
Risk Assessment
Risk Level: medium — Unregistered sales can sometimes signal financial distress or a need for quick capital, and the lack of specific details warrants caution.
Key Players & Entities
- INVO Fertility, Inc. (company) — Registrant
- October 16, 2025 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
- 001-39701 (filing_id) — SEC File Number
- 20-4036208 (ein) — I.R.S. Employer Identification No.
- 5582 Broadcast Court Sarasota , FL 34240 (address) — Principal executive offices
FAQ
What type of equity securities were sold?
The filing does not specify the type of equity securities sold.
How many shares of equity securities were sold?
The filing does not disclose the number of shares sold.
At what price were the equity securities sold?
The filing does not provide the price per share for the equity securities sold.
Who purchased the unregistered equity securities?
The filing does not identify the purchasers of the unregistered equity securities.
What was the aggregate purchase price of the unregistered equity securities?
The filing does not state the aggregate purchase price of the unregistered equity securities.
Filing Stats: 586 words · 2 min read · ~2 pages · Grade level 11.4 · Accepted 2025-10-22 16:05:39
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value IVF The Nasdaq Stock Mark
- $500,000 — rred, with an aggregate stated value of $500,000, for $500,000 in cash. As a result of t
- $0.6285 — price on the C-2 Preferred adjusted to $0.6285 per share. The C-2 Preferred issued pur
Filing Documents
- form8-k.htm (8-K) — 35KB
- 0001493152-25-018911.txt ( ) — 195KB
- ivf-20251016.xsd (EX-101.SCH) — 3KB
- ivf-20251016_lab.xml (EX-101.LAB) — 33KB
- ivf-20251016_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 22, 2025 INVO FERTILITY, INC. /s/ Steven Shum Steven Shum Chief Executive Officer